Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
SparingVision
SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
B2X
B2B
B2C
CEO
Stephane Boissel
Company Operating Status
Active
Country
France
0
United States
0
Crunchbase URL
crunchbase.com/organiz...ngvision
Date Incorporated
2016
Email Address
info@sparingvision.com
0
Facebook URL
@sparingvision
Founder
Jose alain sahel
0
Thierry Léveillard
0
Full Address
Three Logan Square 1717 Arch Street Philadelphia, PA USA
0
5/7 avenue Percier CS40230 75008 Paris France
0
55 rue de Lyon 750012 Paris France
Headquarters
Paris
Industry
Genome editing
Deep Tech
Health technology
Engineering
Biomedical engineering
Tissue engineering
Biopharmaceutical
Healthcare
Technology
Biology
•••
Investors
4BIO Capital
Bpifrance (public entity)
UPMC Enterprises
Foundation Fighting Blindness
Jeito Capital
Ysios Capital
Latest Funding Round Date
October 1, 2020
Latest Funding Round Amount (USD)
53,000,000
Latest Funding Type
Series A
LinkedIn URL
@company/sparingvision
Location
Philadelphia
0
Paris
0
France
Number of Employees (Ranges)
1 – 10
Phone Number
+33143462060
0
Pitchbook URL
pitchbook.com/profiles...178327-99
Technologies Used
CRISPR
Total Funding Amount (USD)
97,500,000
Twitter URL
@SparingVision
Official Website
sparingvision.com
sparingvision.com/en
Find more companies like SparingVision
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE